$0.62 EPS Expected for Fortis Inc. (FTS); RENOVACARE (RCAR) Sellers Decreased By 42.49% Their Shorts

February 7, 2018 - By Marguerite Chambers

Analysts expect Fortis Inc. (TSE:FTS) to report $0.62 EPS on February, 15.They anticipate $0.02 EPS change or 3.13% from last quarter’s $0.64 EPS. T_FTS’s profit would be $260.09M giving it 16.62 P/E if the $0.62 EPS is correct. After having $0.61 EPS previously, Fortis Inc.’s analysts see 1.64% EPS growth. The stock decreased 2.18% or $0.92 during the last trading session, reaching $41.22. About 2.17M shares traded or 142.83% up from the average. Fortis Inc. (TSE:FTS) has 0.00% since February 7, 2017 and is . It has underperformed by 16.70% the S&P500.

RENOVACARE INCORPORATED (OTCMKTS:RCAR) had a decrease of 42.49% in short interest. RCAR’s SI was 11,100 shares in February as released by FINRA. Its down 42.49% from 19,300 shares previously. With 73,500 avg volume, 0 days are for RENOVACARE INCORPORATED (OTCMKTS:RCAR)’s short sellers to cover RCAR’s short positions. The stock increased 9.09% or $0.55 during the last trading session, reaching $6.6. About shares traded. RenovaCare, Inc. (OTCMKTS:RCAR) has 0.00% since February 7, 2017 and is . It has underperformed by 16.70% the S&P500.

Fortis Inc. operates as an electric and gas utility firm in Canada, the United States, and the Caribbean. The company has market cap of $17.29 billion. It generates, transmits, and distributes electricity to approximately 420,000 retail clients in a territory comprising approximately 2,991 square kilometers located in southeastern Arizona, including the greater Tucson metropolitan area in Pima county, as well as parts of Cochise county; and 95,000 retail clients in Arizona??s Mohave and Santa Cruz counties with an aggregate capacity of 2,994 megawatts comprising 54 MW of solar capacity. It has a 16.49 P/E ratio. The firm also sells wholesale electricity to other entities in the western United States; owns gas-fired and hydroelectric generating capacity totaling 64 MW; and distributes natural gas to approximately 994,000 clients in approximately 135 communities in British Columbia, Canada.

Among 7 analysts covering Fortis Incorporated (TSE:FTS), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Fortis Incorporated had 29 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Neutral” rating by JP Morgan given on Monday, February 27. The rating was maintained by RBC Capital Markets on Wednesday, October 7 with “Outperform”. The firm has “Outperform” rating by Raymond James given on Thursday, September 22. On Tuesday, January 17 the stock rating was downgraded by Raymond James to “Mkt Perform”. The stock of Fortis Inc. (TSE:FTS) earned “Sector Perform” rating by IBC on Wednesday, July 20. TD Securities maintained the stock with “Buy” rating in Friday, March 3 report. As per Tuesday, January 24, the company rating was maintained by RBC Capital Markets. The firm has “Outperform” rating given on Friday, February 17 by Scotia Capital. Desjardins Securities maintained Fortis Inc. (TSE:FTS) on Thursday, November 24 with “Buy” rating. The stock of Fortis Inc. (TSE:FTS) earned “Outperform” rating by IBC on Friday, February 17.

RenovaCare, Inc., a development-stage company, focuses on the acquisition, research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. The company has market cap of $502.56 million. The Company’s flagship technology product is CellMist System, which include a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. It currently has negative earnings. The firm was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.